Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Q3ZN
|
||||
| Former ID |
DIB009442
|
||||
| Drug Name |
GS-3435
|
||||
| Indication | Influenza virus [ICD10:J11.1] | Terminated | [1] | ||
| Company |
Gilead Sciences Inc
|
||||
| Structure |
|
Download2D MOL |
|||
| Target and Pathway | |||||
| Target(s) | Neuraminidase | Target Info | Modulator | [2], [3] | |
| KEGG Pathway | Other glycan degradation | ||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005196) | ||||
| REF 2 | Neuraminidase inhibitors: zanamivir and oseltamivir. Ann Pharmacother. 2001 Jan;35(1):57-70. | ||||
| REF 3 | US patent application no. 2010,0081,713, Compositions and methods for treating viral infections. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.